The healthcare firm projects 2026 revenue between $3.8 billion and $4.1 billion while targeting net leverage at or below 2x.
Astrana Health outlined a 2026 revenue outlook of $3.8 billion to $4.1 billion, citing strong Q1 2026 performance. The company attributed growth to controlled medical costs, operating leverage, and new full-risk contracts aligned with underwriting expectations.
Management highlighted early success in risk-based agreements, which contributed to the optimistic forecast. The firm also reaffirmed its net leverage target of at or below 2x, signaling financial discipline amid expansion.
Shares showed muted reaction in after-hours trading as investors digested the guidance, which aligns with prior market expectations.